Global Cord Blood (CORBF) Ratios
Global Cord Blood Ratios
CORBF's free cash flow for Q1 2023 was $-327.00K. For the 2023 fiscal year, CORBF's free cash flow was increased by $0.00 and operating cash flow was $-327.00K. See a summary of the company’s cash flow.
| Ratios | Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 10.73 | 10.05 | 9.93 | 8.64 | 9.42 |
| Quick Ratio | 10.66 | 9.98 | 9.85 | 8.60 | 9.36 |
| Cash Ratio | 10.30 | 9.70 | 9.59 | 8.39 | 9.08 |
| Solvency Ratio | 0.15 | 0.16 | 0.16 | 0.11 | 0.11 |
| Operating Cash Flow Ratio | 0.95 | 1.01 | 1.09 | 1.33 | 1.75 |
| Short-Term Operating Cash Flow Coverage | 4174.20 | 385.52 | 363.43 | 0.00 | 0.00 |
| Net Current Asset Value | $ 3.29B | $ 2.78B | $ 2.33B | $ 2.02B | $ 1.68B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.75 | 1.80 | 1.86 | 1.92 | 1.88 |
| Debt Service Coverage Ratio | 3662.82 | 305.27 | 295.51 | 0.00 | 89.33 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 85.93 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.01 | 0.03 | 0.00 | 0.03 |
| Net Debt to EBITDA | -10.14 | -10.23 | -8.99 | -11.52 | -12.02 |
| Profitability Margins | |||||
| Gross Profit Margin | 85.26% | 84.57% | 84.52% | 81.15% | 80.63% |
| EBIT Margin | 48.97% | 46.99% | 45.77% | 38.68% | 32.75% |
| EBITDA Margin | 52.83% | 51.22% | 49.82% | 43.98% | 37.75% |
| Operating Profit Margin | 48.97% | 46.99% | 45.77% | 38.68% | 29.88% |
| Pretax Profit Margin | 50.50% | 52.67% | 47.39% | 36.12% | 32.40% |
| Net Profit Margin | 40.30% | 43.83% | 38.54% | 29.50% | 25.31% |
| Continuous Operations Profit Margin | 40.98% | 44.51% | 39.11% | 29.92% | 25.71% |
| Net Income Per EBT | 79.81% | 83.22% | 81.32% | 81.67% | 78.11% |
| EBT Per EBIT | 103.12% | 112.09% | 103.54% | 93.40% | 108.46% |
| Return on Assets (ROA) | 5.87% | 6.43% | 6.52% | 4.44% | 4.06% |
| Return on Equity (ROE) | 10.27% | 11.60% | 12.13% | 8.52% | 7.62% |
| Return on Capital Employed (ROCE) | 7.72% | 7.48% | 8.41% | 6.41% | 5.21% |
| Return on Invested Capital (ROIC) | 6.26% | 6.32% | 6.94% | 5.31% | 4.13% |
| Return on Tangible Assets | 5.93% | 6.50% | 6.60% | 4.51% | 4.13% |
| Earnings Yield | 16.88% | 14.09% | 17.19% | 4.83% | 3.17% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.71 | 8.90 | 11.72 | 9.16 | 8.00 |
| Payables Turnover | 22.01 | 18.88 | 9.46 | 5.54 | 15.96 |
| Inventory Turnover | 4.00 | 4.04 | 4.32 | 6.74 | 6.55 |
| Fixed Asset Turnover | 2.61 | 2.30 | 2.32 | 1.81 | 1.69 |
| Asset Turnover | 0.15 | 0.15 | 0.17 | 0.15 | 0.16 |
| Working Capital Turnover Ratio | 0.21 | 0.22 | 0.25 | 0.23 | 0.30 |
| Cash Conversion Cycle | 122.12 | 111.95 | 77.02 | 28.16 | 78.48 |
| Days of Sales Outstanding | 47.36 | 41.01 | 31.15 | 39.84 | 45.60 |
| Days of Inventory Outstanding | 91.35 | 90.27 | 84.45 | 54.18 | 55.75 |
| Days of Payables Outstanding | 16.59 | 19.33 | 38.58 | 65.86 | 22.87 |
| Operating Cycle | 138.71 | 131.28 | 115.60 | 94.02 | 101.35 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 5.05 | 5.19 | 5.13 | 6.53 | 6.87 |
| Free Cash Flow Per Share | 4.89 | 5.02 | 4.93 | 6.28 | 6.31 |
| Dividend Paid and CapEx Coverage Ratio | 31.01 | 30.19 | 25.74 | 8.27 | 12.21 |
| Capital Expenditure Coverage Ratio | 31.01 | 30.19 | 25.74 | 25.81 | 12.21 |
| Operating Cash Flow Coverage Ratio | 4174.20 | 353.74 | 178.34 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.49 | 0.54 | 0.51 | 0.80 | 0.87 |
| Free Cash Flow Yield | 20.01% | 16.90% | 21.91% | 12.62% | 10.05% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 5.92 | 7.10 | 5.82 | 20.72 | 31.55 |
| Price-to-Sales (P/S) Ratio | 2.39 | 3.11 | 2.24 | 6.11 | 7.99 |
| Price-to-Book (P/B) Ratio | 0.61 | 0.82 | 0.71 | 1.77 | 2.40 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 5.00 | 5.92 | 4.56 | 7.92 | 9.95 |
| Price-to-Operating Cash Flow Ratio | 4.84 | 5.72 | 4.39 | 7.62 | 9.14 |
| Price-to-Earnings Growth (PEG) Ratio | -4.13 | 0.89 | 0.09 | 1.01 | 1.25 |
| Enterprise Value Multiple | -5.62 | -4.15 | -4.49 | 2.38 | 9.14 |
| Enterprise Value | -3.69B | -2.47B | -2.73B | 1.03B | 3.23B |
| EV to EBITDA | -5.62 | -4.15 | -4.49 | 2.38 | 9.14 |
| EV to Sales | -2.97 | -2.13 | -2.24 | 1.05 | 3.45 |
| EV to Free Cash Flow | -6.22 | -4.04 | -4.56 | 1.36 | 4.30 |
| EV to Operating Cash Flow | -6.02 | -3.91 | -4.38 | 1.31 | 3.95 |
| Tangible Book Value Per Share | 39.50 | 35.38 | 31.23 | 27.41 | 25.32 |
| Shareholders’ Equity Per Share | 40.14 | 36.05 | 31.94 | 28.17 | 26.13 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.19 | 0.15 | 0.17 | 0.17 | 0.21 |
| Revenue Per Share | 10.23 | 9.54 | 10.05 | 8.13 | 7.86 |
| Net Income Per Share | 4.12 | 4.18 | 3.87 | 2.40 | 1.99 |
| Tax Burden | 0.80 | 0.83 | 0.81 | 0.82 | 0.78 |
| Interest Burden | 1.03 | 1.12 | 1.04 | 0.93 | 0.99 |
| Research & Development to Revenue | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 |
| SG&A to Revenue | 0.15 | 0.15 | 0.16 | 0.17 | 0.26 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.20 | 1.22 | 1.31 | 2.68 | 3.40 |
Currency in CNY